The impact of coronavirus pandemic on the global Antidiabetics market has proved to be quite positive. Unavailability of cure for diabetes and vulnerability of diabetic patients to COVID-19 has enhanced the demand for anti-diabetic drugs across the global. The key players of the market are predicted to unleash myriads of opportunities for the growth of the market in the forthcoming years by their smart strategies.
The recently published research report by Research Dive reflects on the influence of COVID-19 pandemic on the present and forthcoming growth of the global antidiabetics industry. This is a professional and all-inclusive research articulated by specialists by evaluating the major growth driving factors, important regional market situations, future opportunities and scope, and trends & developments in the market during the COVID-19 outbreak.
Download FREE Sample of the Report at: https://www.researchdive.com/download-sample/339
Highlights of the Report
A significant growth has been recorded by the global antidiabetics market in the recent years. The report reveals that the industry is estimated to garner a revenue of $148.3 million by the end of 2027, at a CAGR of 11.1% during the forecast period.
The unprecedented outbreak of coronavirus has helped the growth of the market in a fairly positive way. During the crisis, the market has collected a revenue of $70.9 million owing to the growing demand of anti-diabetic drugs.
Factors Driving the Market Growth amid COVID-19 Pandemic
As our analysts observe, the growing cases of diabetes and non-availability of the perfect treatment for diabetes has compelled people to look for the anti-diabetics drug. Moreover, people with diabetes are more vulnerable to coronavirus. These are the factors driving the growth of global antidiabetics market.
Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/339
Future Scope of the Market
According to the report, the global antidiabetics market is projected to maintain a sustainable growth post the pandemic.
New entrants and leading players including Eli Lilly and Company, Sanofi, Johnson & Johnson Services, Inc., Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Halozyme, Inc., Merck Sharp & Dohme Corp., Novartis AG, Bristol-Myers Squibb Company, Oramed and Pfizer Inc. among others.
The financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments of the key players are also highlighted in the report.
Contact Us:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com
No comments:
Post a Comment